{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:04:38Z","timestamp":1779753878868,"version":"3.53.1"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["20250046"],"award-info":[{"award-number":["20250046"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82300080"],"award-info":[{"award-number":["82300080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82241020"],"award-info":[{"award-number":["82241020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Non-communicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0526700"],"award-info":[{"award-number":["2024ZD0526700"]}]},{"name":"Shenzhen Medical Research Fund","award":["C2404001"],"award-info":[{"award-number":["C2404001"]}]},{"name":"National Key Research and Development Program of China","award":["2022YFC2703900 and 2022YFC2703902"],"award-info":[{"award-number":["2022YFC2703900 and 2022YFC2703902"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"DOI":"10.1186\/s10020-026-01478-5","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:05:30Z","timestamp":1775711130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging significance of E3 ubiquitin ligases and Deubiquitinases in pulmonary hypertension"],"prefix":"10.1186","volume":"32","author":[{"given":"Chao-Wei","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-Shen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Jiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Cheng","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"1478_CR1","doi-asserted-by":"publisher","unstructured":"Akiyama T, Raftery LA, Wharton KA. Bone morphogenetic protein signaling: the pathway and its regulation. Genetics. 2024;226. https:\/\/doi.org\/10.1093\/genetics\/iyad200.","DOI":"10.1093\/genetics\/iyad200"},{"key":"1478_CR2","doi-asserted-by":"publisher","unstructured":"Albanese A, Daly LA, Mennerich D, Kietzmann T, S\u00e9e V. The role of hypoxia-inducible factor post-translational modifications in regulating its localisation, stability, and activity. Int J Mol Sci. 2020;22. https:\/\/doi.org\/10.3390\/ijms22010268.","DOI":"10.3390\/ijms22010268"},{"key":"1478_CR3","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1161\/01.cir.0000012754.72951.3d","volume":"105","author":"C Atkinson","year":"2002","unstructured":"Atkinson C, Stewart S, Upton PD, Machado R, Thomson JR, Trembath RC, Morrell NW. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation. 2002;105:1672\u20138. https:\/\/doi.org\/10.1161\/01.cir.0000012754.72951.3d.","journal-title":"Circulation"},{"key":"1478_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40272-019-00374-2","volume":"22","author":"CM Avitabile","year":"2020","unstructured":"Avitabile CM, Vorhies EE, Ivy DD. Drug treatment of pulmonary hypertension in children. Paediatr Drugs. 2020;22:123\u201347. https:\/\/doi.org\/10.1007\/s40272-019-00374-2.","journal-title":"Paediatr Drugs"},{"key":"1478_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cvr\/cvx187","volume":"114","author":"R Baptista","year":"2018","unstructured":"Baptista R, Marques C, Catarino S, Enguita FJ, Costa MC, Matafome P, Zuzarte M, Castro G, Reis A, Monteiro P, et al. MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1. Cardiovasc Res. 2018;114:53\u201364. https:\/\/doi.org\/10.1093\/cvr\/cvx187.","journal-title":"Cardiovasc Res"},{"key":"1478_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1165\/rcmb.2015-0402OC","volume":"55","author":"JW Barnes","year":"2016","unstructured":"Barnes JW, Kucera ET, Tian L, Mellor NE, Dvorina N, Baldwin WW 3rd, Aldred MA, Farver CF, Comhair SA, Aytekin M, et al. Bone morphogenic protein type 2 receptor mutation-independent mechanisms of disrupted bone morphogenetic protein signaling in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2016;55:564\u201375. https:\/\/doi.org\/10.1165\/rcmb.2015-0402OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1478_CR6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1096\/fj.201600557R","volume":"31","author":"EA Barnes","year":"2017","unstructured":"Barnes EA, Chen CH, Sedan O, Cornfield DN. Loss of smooth muscle cell hypoxia inducible factor-1\u03b1 underlies increased vascular contractility in pulmonary hypertension. Faseb j. 2017;31:650\u201362. https:\/\/doi.org\/10.1096\/fj.201600557R.","journal-title":"Faseb j"},{"key":"1478_CR8","doi-asserted-by":"publisher","first-page":"L761","DOI":"10.1152\/ajplung.00019.2020","volume":"322","author":"IS Bazan","year":"2022","unstructured":"Bazan IS, Kim SJ, Ardito TA, Zhang Y, Shan P, Sauler M, Lee PJ. Sex differences and altered mitophagy in experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2022;322:L761\u20139. https:\/\/doi.org\/10.1152\/ajplung.00019.2020.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1478_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/jcb.29026","volume":"121","author":"S Bian","year":"2020","unstructured":"Bian S. miR-4319 inhibited the development of thyroid cancer by modulating FUS-stabilized SMURF1. J Cell Biochem. 2020;121:174\u201382. https:\/\/doi.org\/10.1002\/jcb.29026.","journal-title":"J Cell Biochem"},{"key":"1478_CR10","doi-asserted-by":"publisher","first-page":"707317","DOI":"10.3389\/fchem.2021.707317","volume":"9","author":"A Bricelj","year":"2021","unstructured":"Bricelj A, Steinebach C, Kuchta R, G\u00fctschow M, Sosi\u010d I. E3 ligase ligands in successful protacs: an overview of syntheses and linker attachment points. Front Chem. 2021;9:707317. https:\/\/doi.org\/10.3389\/fchem.2021.707317.","journal-title":"Front Chem"},{"key":"1478_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41392-022-01152-2","volume":"7","author":"C Cai","year":"2022","unstructured":"Cai C, Tang YD, Zhai J, Zheng C. The RING finger protein family in health and disease. Signal Transduct Target Ther. 2022;7:300. https:\/\/doi.org\/10.1038\/s41392-022-01152-2.","journal-title":"Signal Transduct Target Ther"},{"key":"1478_CR12","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s00018-012-1170-7","volume":"70","author":"Y Cao","year":"2013","unstructured":"Cao Y, Zhang L. A Smurf1 tale: function and regulation of an ubiquitin ligase in multiple cellular networks. Cell Mol Life Sci. 2013;70:2305\u201317. https:\/\/doi.org\/10.1007\/s00018-012-1170-7.","journal-title":"Cell Mol Life Sci"},{"key":"1478_CR15","doi-asserted-by":"publisher","first-page":"111982","DOI":"10.1016\/j.yexcr.2020.111982","volume":"390","author":"M Chen","year":"2020","unstructured":"Chen M, Ding Z, Zhang F, Shen H, Zhu L, Yang H, Chen S. A20 attenuates hypoxia-induced pulmonary arterial hypertension by inhibiting NF-\u03baB activation and pulmonary artery smooth muscle cell proliferation. Exp Cell Res. 2020;390:111982. https:\/\/doi.org\/10.1016\/j.yexcr.2020.111982.","journal-title":"Exp Cell Res"},{"key":"1478_CR14","doi-asserted-by":"publisher","unstructured":"Chen IC, Liu YC, Wu YH, Lo SH, Wang SC, Li CY, Dai ZK, Hsu JH, Yeh CY, Tseng YH. 2022. Proteasome inhibitors decrease the viability of pulmonary arterial smooth muscle cells by restoring mitofusin-2 expression under hypoxic conditions. Biomedicines 10. https:\/\/doi.org\/10.3390\/biomedicines10040873","DOI":"10.3390\/biomedicines10040873"},{"key":"1478_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s10020-024-00975-9","volume":"30","author":"C Chen","year":"2024","unstructured":"Chen C, Qin S, Song X, Wen J, Huang W, Sheng Z, Li X, Cao Y. PI3K p85\u03b1\/HIF-1\u03b1 accelerates the development of pulmonary arterial hypertension by regulating fatty acid uptake and mitophagy. Mol Med. 2024a;30:208. https:\/\/doi.org\/10.1186\/s10020-024-00975-9.","journal-title":"Mol Med"},{"key":"1478_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2024.07.003","volume":"195","author":"W Chen","year":"2024","unstructured":"Chen W, Chen A, Lian G, Yan Y, Liu J, Wu J, Gao G, Xie L. Zinc attenuates monocrotaline-induced pulmonary hypertension in rats through upregulation of A20. J Mol Cell Cardiol. 2024b;195:24\u201335. https:\/\/doi.org\/10.1016\/j.yjmcc.2024.07.003.","journal-title":"J Mol Cell Cardiol"},{"key":"1478_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12931-025-03419-y","volume":"26","author":"Y Chen","year":"2025","unstructured":"Chen Y, Lv Y, Yang M, Qian Z, Jiang X, Jiang Z, Kong C, Gu Y, Deng Y, Chen SL. The P4HA1\/HIF1\u03b1 feedback loop modulates endothelial dysfunction in pulmonary hypertension. Respir Res. 2025;26:353. https:\/\/doi.org\/10.1186\/s12931-025-03419-y.","journal-title":"Respir Res"},{"key":"1478_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40495-016-0066-x","volume":"2","author":"SF Cook","year":"2016","unstructured":"Cook SF, Bies RR. Disease progression modeling: key concepts and recent developments. Curr Pharmacol Rep. 2016;2:221\u201330. https:\/\/doi.org\/10.1007\/s40495-016-0066-x.","journal-title":"Curr Pharmacol Rep"},{"key":"1478_CR19","doi-asserted-by":"publisher","first-page":"L1115","DOI":"10.1152\/ajplung.00476.2019","volume":"318","author":"CD Cool","year":"2020","unstructured":"Cool CD, Kuebler WM, Bogaard HJ, Spiekerkoetter E, Nicolls MR, Voelkel NF. The hallmarks of severe pulmonary arterial hypertension: the cancer hypothesis-ten years later. Am J Physiol Lung Cell Mol Physiol. 2020;318:L1115\u201330. https:\/\/doi.org\/10.1152\/ajplung.00476.2019.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1478_CR20","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1042\/bst20200237","volume":"48","author":"TR Cotton","year":"2020","unstructured":"Cotton TR, Lechtenberg BC. Chain reactions: molecular mechanisms of RBR ubiquitin ligases. Biochem Soc Trans. 2020;48:1737\u201350. https:\/\/doi.org\/10.1042\/bst20200237.","journal-title":"Biochem Soc Trans"},{"key":"1478_CR21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.dnarep.2009.01.008","volume":"8","author":"AS Coutts","year":"2009","unstructured":"Coutts AS, Adams CJ, La Thangue NB. p53 ubiquitination by Mdm2: a never ending tail? DNA Repair (Amst). 2009;8:483\u201390. https:\/\/doi.org\/10.1016\/j.dnarep.2009.01.008.","journal-title":"DNA Repair (Amst)"},{"key":"1478_CR22","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1164\/rccm.201412-2262OC","volume":"192","author":"A Crosby","year":"2015","unstructured":"Crosby A, Soon E, Jones FM, Southwood MR, Haghighat L, Toshner MR, Raine T, Horan I, Yang P, Moore S, et al. Hepatic shunting of eggs and pulmonary vascular remodeling in Bmpr2(+\/-) mice with schistosomiasis. Am J Respir Crit Care Med. 2015;192:1355\u201365. https:\/\/doi.org\/10.1164\/rccm.201412-2262OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1478_CR23","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1038\/emboj.2011.155","volume":"30","author":"Y Cui","year":"2011","unstructured":"Cui Y, He S, Xing C, Lu K, Wang J, Xing G, Meng A, Jia S, He F, Zhang L. SCFFBXL\u00b9\u2075 regulates BMP signalling by directing the degradation of HECT-type ubiquitin ligase Smurf1. Embo j. 2011;30:2675\u201389. https:\/\/doi.org\/10.1038\/emboj.2011.155.","journal-title":"Embo j"},{"key":"1478_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1165\/rcmb.2024-0353OC","volume":"73","author":"A Czerwinski","year":"2025","unstructured":"Czerwinski A, Sidlowski P, Mooers E, Liu Y, Teng RJ, Pritchard K Jr., Jing X, Kumar S, Pan AY, Liu P, et al. Stub1 acetylation by CBP\/p300 attenuates chronic hypoxic-driven pulmonary hypertension by suppressing HIF-2\u03b1. Am J Respir Cell Mol Biol. 2025;73:369\u201382. https:\/\/doi.org\/10.1165\/rcmb.2024-0353OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1478_CR25","doi-asserted-by":"publisher","first-page":"204589401987534","DOI":"10.1177\/2045894019875343","volume":"9","author":"F Dong","year":"2019","unstructured":"Dong F, Zhang J. Inactivation of carboxyl terminus of Hsc70-interacting protein prevents hypoxia-induced pulmonary arterial smooth muscle cells proliferation by reducing intracellular Ca(2+) concentration. Pulm Circ. 2019;9:2045894019875343. https:\/\/doi.org\/10.1177\/2045894019875343.","journal-title":"Pulm Circ"},{"key":"1478_CR26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s11684-019-0734-4","volume":"14","author":"J Du","year":"2020","unstructured":"Du J, Fu L, Sui Y, Zhang L. The function and regulation of OTU deubiquitinases. Front Med. 2020;14:542\u201363. https:\/\/doi.org\/10.1007\/s11684-019-0734-4.","journal-title":"Front Med"},{"key":"1478_CR27","doi-asserted-by":"publisher","unstructured":"Du M, Jiang H, Liu H, Zhao X, Zhou Y, Zhou F, Piao C, Xu G, Ma F, Wang J, et al. Single-cell RNA sequencing reveals that BMPR2 mutation regulates right ventricular function via ID genes. Eur Respir J. 2022;60. https:\/\/doi.org\/10.1183\/13993003.00327-2021.","DOI":"10.1183\/13993003.00327-2021"},{"key":"1478_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.semcancer.2020.07.005","volume":"79","author":"MJ Duffy","year":"2022","unstructured":"Duffy MJ, Synnott NC, O\u2019Grady S, Crown J. Targeting p53 for the treatment of cancer. Semin Cancer Biol. 2022;79:58\u201367. https:\/\/doi.org\/10.1016\/j.semcancer.2020.07.005.","journal-title":"Semin Cancer Biol"},{"key":"1478_CR29","doi-asserted-by":"publisher","unstructured":"Evans CE. Hypoxia-inducible factor signaling in inflammatory lung injury and repair. Cells. 2022;11. https:\/\/doi.org\/10.3390\/cells11020183.","DOI":"10.3390\/cells11020183"},{"key":"1478_CR30","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.chembiol.2011.10.017","volume":"18","author":"AC Faesen","year":"2011","unstructured":"Faesen AC, Luna-Vargas MP, Geurink PP, Clerici M, Merkx R, van Dijk WJ, Hameed DS, El Oualid F, Ovaa H, Sixma TK. The differential modulation of USP activity by internal regulatory domains, interactors and eight ubiquitin chain types. Chem Biol. 2011;18:1550\u201361. https:\/\/doi.org\/10.1016\/j.chembiol.2011.10.017.","journal-title":"Chem Biol"},{"key":"1478_CR31","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1038\/onc.2013.410","volume":"33","author":"R F\u00e5hraeus","year":"2014","unstructured":"F\u00e5hraeus R, Olivares-Illana V. MDM2\u2019s social network. Oncogene. 2014;33:4365\u201376. https:\/\/doi.org\/10.1038\/onc.2013.410.","journal-title":"Oncogene"},{"key":"1478_CR32","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10555-017-9702-0","volume":"36","author":"Y Fang","year":"2017","unstructured":"Fang Y, Shen X. Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications. Cancer Metastasis Rev. 2017;36:669\u201382. https:\/\/doi.org\/10.1007\/s10555-017-9702-0.","journal-title":"Cancer Metastasis Rev"},{"key":"1478_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4103\/2045-8932.87293","volume":"1","author":"JP Fessel","year":"2011","unstructured":"Fessel JP, Loyd JE, Austin ED. The genetics of pulmonary arterial hypertension in the post-BMPR2 era. Pulm Circ. 2011;1:305\u201319. https:\/\/doi.org\/10.4103\/2045-8932.87293.","journal-title":"Pulm Circ"},{"key":"1478_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-pharmtox-010919-023603","volume":"60","author":"LD Fricker","year":"2020","unstructured":"Fricker LD. Proteasome inhibitor drugs. Annu Rev Pharmacol Toxicol. 2020;60:457\u201376. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010919-023603.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1478_CR35","first-page":"2093","volume":"95","author":"D Fu","year":"2015","unstructured":"Fu D, Dai A, Hu R, Tian H, Chen Y, Zhu L. Regulatory mechanism of Siah1 in the pathogenesis of rat hypoxic pulmonary hypertension. Zhonghua Yi Xue Za Zhi. 2015;95:2093\u20138.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"1478_CR36","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu M, Hu Y, Lan T, Guan KL, Luo T, Luo M. The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Ther. 2022;7:376. https:\/\/doi.org\/10.1038\/s41392-022-01191-9.","journal-title":"Signal Transduct Target Ther"},{"key":"1478_CR37","doi-asserted-by":"publisher","first-page":"35660","DOI":"10.1074\/jbc.M710496200","volume":"283","author":"E Fukunaga","year":"2008","unstructured":"Fukunaga E, Inoue Y, Komiya S, Horiguchi K, Goto K, Saitoh M, Miyazawa K, Koinuma D, Hanyu A, Imamura T. Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells. J Biol Chem. 2008;283:35660\u20137. https:\/\/doi.org\/10.1074\/jbc.M710496200.","journal-title":"J Biol Chem"},{"key":"1478_CR38","doi-asserted-by":"publisher","unstructured":"Gaete D, Rodriguez D, Watts D, Sormendi S, Chavakis T, Wielockx B. HIF-Prolyl Hydroxylase domain proteins (PHDs) in cancer-potential targets for anti-tumor therapy? cancers (Basel). 2021;13. https:\/\/doi.org\/10.3390\/cancers13050988.","DOI":"10.3390\/cancers13050988"},{"key":"1478_CR39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/pros.22935","volume":"75","author":"X Gang","year":"2015","unstructured":"Gang X, Wang G, Huang H. Androgens regulate SMAD ubiquitination regulatory factor-1 expression and prostate cancer cell invasion. Prostate. 2015;75:561\u201372. https:\/\/doi.org\/10.1002\/pros.22935.","journal-title":"Prostate"},{"key":"1478_CR40","doi-asserted-by":"publisher","unstructured":"Grynblat J, Khouri C, Hlavaty A, Ja\u00efs X, Savale L, Chaumais MC, Kularatne M, Jevnikar M, Boucly A, Antigny F, et al. Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors. Eur Respir J. 2024;63. https:\/\/doi.org\/10.1183\/13993003.02158-2023.","DOI":"10.1183\/13993003.02158-2023"},{"key":"1478_CR41","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.bbrc.2014.06.134","volume":"450","author":"H Guo","year":"2014","unstructured":"Guo H, Wu F, Wang Y, Yan C, Su W. Overexpressed ubiquitin ligase Cullin7 in breast cancer promotes cell proliferation and invasion via down-regulating p53. Biochem Biophys Res Commun. 2014;450:1370\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2014.06.134.","journal-title":"Biochem Biophys Res Commun"},{"key":"1478_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, Zeng C, Zhou T, Zhang J. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024a;9:53. https:\/\/doi.org\/10.1038\/s41392-024-01757-9.","journal-title":"Signal Transduct Target Ther"},{"key":"1478_CR43","doi-asserted-by":"publisher","first-page":"114254","DOI":"10.1016\/j.yexcr.2024.114254","volume":"442","author":"YZ Guo","year":"2024","unstructured":"Guo YZ, Cui HY, Cai MY, Wang D, Deng WP, Hu CP. SOX9 promotes hypoxic pulmonary hypertension through stabilization of DPP4 in pulmonary artery smooth muscle cells. Exp Cell Res. 2024b;442:114254. https:\/\/doi.org\/10.1016\/j.yexcr.2024.114254.","journal-title":"Exp Cell Res"},{"key":"1478_CR44","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1021\/acs.jmedchem.0c01897","volume":"64","author":"M Hanafi","year":"2021","unstructured":"Hanafi M, Chen X, Neamati N. Discovery of a Napabucasin PROTAC as an Effective Degrader of the E3 Ligase ZFP91. J Med Chem. 2021;64:1626\u201348. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01897.","journal-title":"J Med Chem"},{"key":"1478_CR45","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1016\/j.bbrc.2018.08.095","volume":"503","author":"X Hao","year":"2018","unstructured":"Hao X, Ma C, Chen S, Dang J, Cheng X, Zhu D. Reverse the down regulation of miR-92b-3p by hypoxia can suppress the proliferation of pulmonary artery smooth muscle cells by targeting USP28. Biochem Biophys Res Commun. 2018;503:3064\u201377. https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.095.","journal-title":"Biochem Biophys Res Commun"},{"key":"1478_CR46","doi-asserted-by":"publisher","first-page":"105273","DOI":"10.1016\/j.bioorg.2021.105273","volume":"116","author":"C Harakandi","year":"2021","unstructured":"Harakandi C, Nininahazwe L, Xu H, Liu B, He C, Zheng YC, Zhang H. Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy. Bioorg Chem. 2021;116:105273. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105273.","journal-title":"Bioorg Chem"},{"key":"1478_CR47","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1161\/circulationaha.118.033744","volume":"139","author":"A Hautefort","year":"2019","unstructured":"Hautefort A, Mendes-Ferreira P, Sabourin J, Manaud G, Bertero T, Rucker-Martin C, Riou M, Ad\u00e3o R, Manoury B, Lambert M, et al. Bmpr2 mutant rats develop pulmonary and cardiac characteristics of pulmonary arterial hypertension. Circulation. 2019;139:932\u201348. https:\/\/doi.org\/10.1161\/circulationaha.118.033744.","journal-title":"Circulation"},{"key":"1478_CR48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.healun.2019.08.022","volume":"39","author":"T Hiraide","year":"2020","unstructured":"Hiraide T, Kataoka M, Suzuki H, Aimi Y, Chiba T, Isobe S, Katsumata Y, Goto S, Kanekura K, Yamada Y, et al. Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension. J Heart Lung Transpl. 2020;39:103\u201312. https:\/\/doi.org\/10.1016\/j.healun.2019.08.022.","journal-title":"J Heart Lung Transpl"},{"key":"1478_CR49","doi-asserted-by":"publisher","first-page":"26604","DOI":"10.1038\/s41598-024-77388-5","volume":"14","author":"T Hiraide","year":"2024","unstructured":"Hiraide T, Tsuda N, Momoi M, Shinya Y, Sano M, Fukuda K, Shibahara J, Kuramoto J, Kanai Y, Kosaki K, et al. CXCL12\/CXCR4 pathway as a novel therapeutic target for RNF213-associated pulmonary arterial hypertension. Sci Rep. 2024;14:26604. https:\/\/doi.org\/10.1038\/s41598-024-77388-5.","journal-title":"Sci Rep"},{"key":"1478_CR50","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/s2213-2600(15)00543-3","volume":"4","author":"MM Hoeper","year":"2016","unstructured":"Hoeper MM, Humbert M, Souza R, Idrees M, Kawut SM, Sliwa-Hahnle K, Jing ZC, Gibbs JS. A global view of pulmonary hypertension. Lancet Respir Med. 2016;4:306\u201322. https:\/\/doi.org\/10.1016\/s2213-2600(15)00543-3.","journal-title":"Lancet Respir Med"},{"key":"1478_CR52","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10863-021-09880-w","volume":"53","author":"Z Hu","year":"2021","unstructured":"Hu Z, Song Q, Ma H, Guo Y, Zhang T, Xie H, Luo X. TRIM32 inhibits the proliferation and migration of pulmonary artery smooth muscle cells through the inactivation of PI3K\/Akt pathway in pulmonary arterial hypertension. J Bioenerg Biomembr. 2021;53:309\u201320. https:\/\/doi.org\/10.1007\/s10863-021-09880-w.","journal-title":"J Bioenerg Biomembr"},{"key":"1478_CR51","doi-asserted-by":"publisher","first-page":"175093","DOI":"10.1016\/j.ejphar.2022.175093","volume":"928","author":"P Hu","year":"2022","unstructured":"Hu P, Xu Y, Jiang Y, Huang J, Liu Y, Wang D, Tao T, Sun Z, Liu Y. The mechanism of the imbalance between proliferation and ferroptosis in pulmonary artery smooth muscle cells based on the activation of SLC7A11. Eur J Pharmacol. 2022;928:175093. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175093.","journal-title":"Eur J Pharmacol"},{"key":"1478_CR53","doi-asserted-by":"publisher","unstructured":"Humbert M, Guignabert C, Bonnet S, Dorfmuller P, Klinger JR, Nicolls MR, Olschewski AJ, Pullamsetti SS, Schermuly RT, Stenmark KR, et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019;53. https:\/\/doi.org\/10.1183\/13993003.01887-2018.","DOI":"10.1183\/13993003.01887-2018"},{"key":"1478_CR54","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, et al. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43:3618\u2013731. https:\/\/doi.org\/10.1093\/eurheartj\/ehac237.","journal-title":"Eur Heart J"},{"key":"1478_CR55","doi-asserted-by":"publisher","first-page":"14079","DOI":"10.1038\/ncomms14079","volume":"8","author":"LA Hurst","year":"2017","unstructured":"Hurst LA, Dunmore BJ, Long L, Crosby A, Al-Lamki R, Deighton J, Southwood M, Yang X, Nikolic MZ, Herrera B, et al. TNF\u03b1 drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling. Nat Commun. 2017;8:14079. https:\/\/doi.org\/10.1038\/ncomms14079.","journal-title":"Nat Commun"},{"key":"1478_CR56","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1182\/bloodadvances.2020002754","volume":"5","author":"AJ Jang","year":"2021","unstructured":"Jang AJ, Chang SS, Park C, Lee CM, Benza RL, Passineau MJ, Ma J, Archer DR, Sutliff RL, Hart CM, et al. PPAR\u03b3 increases HUWE1 to attenuate NF-\u03baB\/p65 and sickle cell disease with pulmonary hypertension. Blood Adv. 2021;5:399\u2013413. https:\/\/doi.org\/10.1182\/bloodadvances.2020002754.","journal-title":"Blood Adv"},{"key":"1478_CR57","doi-asserted-by":"publisher","first-page":"11388","DOI":"10.1073\/pnas.0609467104","volume":"104","author":"P Jung","year":"2007","unstructured":"Jung P, Verdoodt B, Bailey A, Yates JR 3rd, Menssen A, Hermeking H. Induction of cullin 7 by DNA damage attenuates p53 function. Proc Natl Acad Sci U S A. 2007;104:11388\u201393. https:\/\/doi.org\/10.1073\/pnas.0609467104.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1478_CR58","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.healun.2023.09.003","volume":"43","author":"EM Jutant","year":"2024","unstructured":"Jutant EM, Chelgham MK, Ottaviani M, Thuillet R, Le Vely B, Humbert M, Guignabert C, Tu L, Huertas A. Central role of ubiquitin-specific protease 8 in leptin signaling pathway in pulmonary arterial hypertension. J Heart Lung Transpl. 2024;43:120\u201333. https:\/\/doi.org\/10.1016\/j.healun.2023.09.003.","journal-title":"J Heart Lung Transpl"},{"key":"1478_CR59","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1074\/jbc.M509430200","volume":"281","author":"H Kaneki","year":"2006","unstructured":"Kaneki H, Guo R, Chen D, Yao Z, Schwarz EM, Zhang YE, Boyce BF, Xing L. Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. J Biol Chem. 2006;281:4326\u201333. https:\/\/doi.org\/10.1074\/jbc.M509430200.","journal-title":"J Biol Chem"},{"key":"1478_CR60","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12943-022-01707-5","volume":"22","author":"JM Kelm","year":"2023","unstructured":"Kelm JM, Pandey DS, Malin E, Kansou H, Arora S, Kumar R, Gavande NS. PROTAC\u2019ing oncoproteins: targeted protein degradation for cancer therapy. Mol Cancer. 2023;22:62. https:\/\/doi.org\/10.1186\/s12943-022-01707-5.","journal-title":"Mol Cancer"},{"key":"1478_CR61","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1161\/circresaha.121.319100","volume":"130","author":"TV Kudryashova","year":"2022","unstructured":"Kudryashova TV, Dabral S, Nayakanti S, Ray A, Goncharov DA, Avolio T, Shen Y, Rode A, Pena A, Jiang L, et al. Noncanonical HIPPO\/MST Signaling via BUB3 and FOXO drives pulmonary vascular cell growth and survival. Circ Res. 2022;130:760\u201378. https:\/\/doi.org\/10.1161\/circresaha.121.319100.","journal-title":"Circ Res"},{"key":"1478_CR66","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1042\/bst20231547","volume":"52","author":"W Li","year":"2024","unstructured":"Li W, Quigley K. Bone morphogenetic protein signalling in pulmonary arterial hypertension: revisiting the BMPRII connection. Biochem Soc Trans. 2024;52:1515\u201328. https:\/\/doi.org\/10.1042\/bst20231547.","journal-title":"Biochem Soc Trans"},{"key":"1478_CR64","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/jcmm.12816","volume":"20","author":"J Li","year":"2016","unstructured":"Li J, Zhang L, Zhang Y, Liu Y, Zhang H, Wei L, Shen T, Jiang C, Zhu D. A20 deficiency leads to angiogenesis of pulmonary artery endothelial cells through stronger NF-\u03baB activation under hypoxia. J Cell Mol Med. 2016;20:1319\u201328. https:\/\/doi.org\/10.1111\/jcmm.12816.","journal-title":"J Cell Mol Med"},{"key":"1478_CR62","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.celrep.2019.01.013","volume":"26","author":"CG Li","year":"2019","unstructured":"Li CG, Mahon C, Sweeney NM, Verschueren E, Kantamani V, Li D, Hennigs JK, Marciano DP, Diebold I, Abu-Halawa O, et al. PPAR\u03b3 Interaction with UBR5\/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis. Cell Rep. 2019;26:1333\u2013e13431337. https:\/\/doi.org\/10.1016\/j.celrep.2019.01.013.","journal-title":"Cell Rep"},{"key":"1478_CR65","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1002\/cam4.2992","volume":"9","author":"T Li","year":"2020","unstructured":"Li T, Xing Y, Yang F, Sun Y, Zhang S, Wang Q, Zhang W. LncRNA SNHG3 sponges miR-577 to up-regulate SMURF1 expression in prostate cancer. Cancer Med. 2020;9:3852\u201362. https:\/\/doi.org\/10.1002\/cam4.2992.","journal-title":"Cancer Med"},{"key":"1478_CR67","doi-asserted-by":"publisher","unstructured":"Li Y, Li S, Wu H. 2022. Ubiquitination-proteasome system (UPS) and autophagy two main protein degradation machineries in response to cell stress. Cells 11. https:\/\/doi.org\/10.3390\/cells11050851","DOI":"10.3390\/cells11050851"},{"key":"1478_CR63","doi-asserted-by":"publisher","first-page":"101817","DOI":"10.1016\/j.arr.2022.101817","volume":"84","author":"J Li","year":"2023","unstructured":"Li J, Yang D, Li Z, Zhao M, Wang D, Sun Z, Wen P, Dai Y, Gou F, Ji Y, et al. PINK1\/Parkin-mediated mitophagy in neurodegenerative diseases. Ageing Res Rev. 2023;84:101817. https:\/\/doi.org\/10.1016\/j.arr.2022.101817.","journal-title":"Ageing Res Rev"},{"key":"1478_CR68","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1161\/hypertensionaha.124.23542","volume":"82","author":"D Lin","year":"2025","unstructured":"Lin D, Hu L, Wei D, Li Y, Yu Y, Wang Q, Sun X, Shen Y, Yu Y, Li K, et al. Peli1 Deficiency in Macrophages Attenuates Pulmonary Hypertension by Enhancing Foxp1-Mediated Transcriptional Inhibition of IL-6. Hypertension. 2025;82:445\u201359. https:\/\/doi.org\/10.1161\/hypertensionaha.124.23542.","journal-title":"Hypertension"},{"key":"1478_CR69","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.bbrc.2020.11.040","volume":"534","author":"L Linqing","year":"2021","unstructured":"Linqing L, Yuhan Q, Erfei L, Yong Q, Dong W, Chengchun T, Gaoliang Y, Bo L. Hypoxia-induced PINK1\/Parkin-mediated mitophagy promotes pulmonary vascular remodeling. Biochem Biophys Res Commun. 2021;534:568\u201375. https:\/\/doi.org\/10.1016\/j.bbrc.2020.11.040.","journal-title":"Biochem Biophys Res Commun"},{"key":"1478_CR70","doi-asserted-by":"publisher","first-page":"172698","DOI":"10.1016\/j.ejphar.2019.172698","volume":"864","author":"H Liu","year":"2019","unstructured":"Liu H, Ge XY, Huang N, Liu T, Yao MZ, Zhang Z, Qian ZX, Hu CP. Up-regulation of cullin7 promotes proliferation and migration of pulmonary artery smooth muscle cells in hypoxia-induced pulmonary hypertension. Eur J Pharmacol. 2019;864:172698. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172698.","journal-title":"Eur J Pharmacol"},{"key":"1478_CR72","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41419-022-05091-2","volume":"13","author":"R Liu","year":"2022","unstructured":"Liu R, Xu C, Zhang W, Cao Y, Ye J, Li B, Jia S, Weng L, Liu Y, Liu L, et al. FUNDC1-mediated mitophagy and HIF1\u03b1 activation drives pulmonary hypertension during hypoxia. Cell Death Dis. 2022;13:634. https:\/\/doi.org\/10.1038\/s41419-022-05091-2.","journal-title":"Cell Death Dis"},{"key":"1478_CR71","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.imlet.2023.10.005","volume":"263","author":"H Liu","year":"2023","unstructured":"Liu H, Wang Y, Zhang Q, Liu C, Ma Y, Huang P, Ge R, Ma L. Macrophage-derived inflammation promotes pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension mice. Immunol Lett. 2023a;263:113\u201322. https:\/\/doi.org\/10.1016\/j.imlet.2023.10.005.","journal-title":"Immunol Lett"},{"key":"1478_CR74","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1186\/s12967-023-04712-4","volume":"21","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhu L, Ming Y, Wu Z, Zhang L, Chen Q, Qi Y. A role of TRIM59 in pulmonary hypertension: modulating the protein ubiquitylation modification. J Transl Med. 2023b;21:821. https:\/\/doi.org\/10.1186\/s12967-023-04712-4.","journal-title":"J Transl Med"},{"key":"1478_CR73","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s00018-024-05291-3","volume":"81","author":"Y Liu","year":"2024","unstructured":"Liu Y, Tang B, Wang H, Lu M. Otud6b induces pulmonary arterial hypertension by mediating the Calpain-1\/HIF-1\u03b1 signaling pathway. Cell Mol Life Sci. 2024;81:258. https:\/\/doi.org\/10.1007\/s00018-024-05291-3.","journal-title":"Cell Mol Life Sci"},{"key":"1478_CR75","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nm.3877","volume":"21","author":"L Long","year":"2015","unstructured":"Long L, Ormiston ML, Yang X, Southwood M, Gr\u00e4f S, Machado RD, Mueller M, Kinzel B, Yung LM, Wilkinson JM, et al. Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension. Nat Med. 2015;21:777\u201385. https:\/\/doi.org\/10.1038\/nm.3877.","journal-title":"Nat Med"},{"key":"1478_CR76","doi-asserted-by":"publisher","first-page":"843927","DOI":"10.3389\/fneur.2022.843927","volume":"13","author":"Y Luo","year":"2022","unstructured":"Luo Y, Cao Z, Wu S, Sun X. Ring finger protein 213 in moyamoya disease with pulmonary arterial hypertension: a mini-review. Front Neurol. 2022;13:843927. https:\/\/doi.org\/10.3389\/fneur.2022.843927.","journal-title":"Front Neurol"},{"key":"1478_CR78","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","volume":"88","author":"S Ma","year":"2019","unstructured":"Ma S, Meng Z, Chen R, Guan KL. The hippo pathway: biology and pathophysiology. Annu Rev Biochem. 2019;88:577\u2013604. https:\/\/doi.org\/10.1146\/annurev-biochem-013118-111829.","journal-title":"Annu Rev Biochem"},{"key":"1478_CR77","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13578-022-00744-3","volume":"12","author":"C Ma","year":"2022","unstructured":"Ma C, Wang X, He S, Zhang L, Bai J, Qu L, Qi J, Zheng X, Zhu X, Mei J, et al. Ubiquitinated AIF is a major mediator of hypoxia-induced mitochondrial dysfunction and pulmonary artery smooth muscle cell proliferation. Cell Biosci. 2022;12:9. https:\/\/doi.org\/10.1186\/s13578-022-00744-3.","journal-title":"Cell Biosci"},{"key":"1478_CR79","doi-asserted-by":"publisher","first-page":"472","DOI":"10.17305\/bb.2024.10720","volume":"25","author":"X Ma","year":"2025","unstructured":"Ma X, Cao Y, Yang D, Dong Z, Wang X. Inhibition of RUNX1 slows the progression of pulmonary hypertension by targeting CBX5. Biomol Biomed. 2025;25:472\u201381. https:\/\/doi.org\/10.17305\/bb.2024.10720.","journal-title":"Biomol Biomed"},{"key":"1478_CR80","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3892\/ol.2023.14093","volume":"26","author":"Y Meng","year":"2023","unstructured":"Meng Y, Hong C, Yang S, Qin Z, Yang L, Huang Y. Roles of USP9X in cellular functions and tumorigenesis (Review). Oncol Lett. 2023;26:506. https:\/\/doi.org\/10.3892\/ol.2023.14093.","journal-title":"Oncol Lett"},{"key":"1478_CR81","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","volume":"86","author":"TET Mevissen","year":"2017","unstructured":"Mevissen TET, Komander D. Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem. 2017;86:159\u201392. https:\/\/doi.org\/10.1146\/annurev-biochem-061516-044916.","journal-title":"Annu Rev Biochem"},{"key":"1478_CR82","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1161\/circulationaha.113.002434","volume":"127","author":"N Mouraret","year":"2013","unstructured":"Mouraret N, Marcos E, Abid S, Gary-Bobo G, Saker M, Houssaini A, Dubois-Rande JL, Boyer L, Boczkowski J, Derumeaux G, et al. Activation of lung p53 by Nutlin-3a prevents and reverses experimental pulmonary hypertension. Circulation. 2013;127:1664\u201376. https:\/\/doi.org\/10.1161\/circulationaha.113.002434.","journal-title":"Circulation"},{"key":"1478_CR83","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cellsig.2018.10.015","volume":"54","author":"K Murakami","year":"2019","unstructured":"Murakami K, Etlinger JD. Role of SMURF1 ubiquitin ligase in BMP receptor trafficking and signaling. Cell Signal. 2019;54:139\u201349. https:\/\/doi.org\/10.1016\/j.cellsig.2018.10.015.","journal-title":"Cell Signal"},{"key":"1478_CR84","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1258\/ebm.2010.009383","volume":"235","author":"K Murakami","year":"2010","unstructured":"Murakami K, Mathew R, Huang J, Farahani R, Peng H, Olson SC, Etlinger JD. Smurf1 ubiquitin ligase causes downregulation of BMP receptors and is induced in monocrotaline and hypoxia models of pulmonary arterial hypertension. Exp Biol Med (Maywood). 2010;235:805\u201313. https:\/\/doi.org\/10.1258\/ebm.2010.009383.","journal-title":"Exp Biol Med (Maywood)"},{"key":"1478_CR85","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13395-020-00229-2","volume":"10","author":"T Nguyen","year":"2020","unstructured":"Nguyen T, Bowen TS, Augstein A, Schauer A, Gasch A, Linke A, Labeit S, Adams V. Expression of MuRF1 or MuRF2 is essential for the induction of skeletal muscle atrophy and dysfunction in a murine pulmonary hypertension model. Skelet Muscle. 2020;10:12. https:\/\/doi.org\/10.1186\/s13395-020-00229-2.","journal-title":"Skelet Muscle"},{"key":"1478_CR86","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1016\/j.febslet.2010.05.034","volume":"584","author":"J Nie","year":"2010","unstructured":"Nie J, Wu M, Wang J, Xing G, He F, Zhang L. REGgamma proteasome mediates degradation of the ubiquitin ligase Smurf1. FEBS Lett. 2010;584:3021\u20137. https:\/\/doi.org\/10.1016\/j.febslet.2010.05.034.","journal-title":"FEBS Lett"},{"key":"1478_CR87","doi-asserted-by":"publisher","first-page":"e104705","DOI":"10.15252\/embj.2020104705","volume":"40","author":"M Onishi","year":"2021","unstructured":"Onishi M, Yamano K, Sato M, Matsuda N, Okamoto K. Molecular mechanisms and physiological functions of mitophagy. Embo j. 2021;40:e104705. https:\/\/doi.org\/10.15252\/embj.2020104705.","journal-title":"Embo j"},{"key":"1478_CR88","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.cell.2024.02.043","volume":"187","author":"M Oren","year":"2024","unstructured":"Oren M, Prives C. p53: A tale of complexity and context. Cell. 2024;187:1569\u201373. https:\/\/doi.org\/10.1016\/j.cell.2024.02.043.","journal-title":"Cell"},{"key":"1478_CR89","doi-asserted-by":"publisher","unstructured":"Pan X, Wu S, Wei W, Chen Z, Wu Y, Gong K. 2022. Structural and functional basis of JAMM Deubiquitinating enzymes in disease. Biomolecules 12. https:\/\/doi.org\/10.3390\/biom12070910","DOI":"10.3390\/biom12070910"},{"key":"1478_CR90","doi-asserted-by":"publisher","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","volume":"28","author":"S Pickles","year":"2018","unstructured":"Pickles S, Vigi\u00e9 P, Youle RJ. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr Biol. 2018;28:R170\u201385. https:\/\/doi.org\/10.1016\/j.cub.2018.01.004.","journal-title":"Curr Biol"},{"key":"1478_CR91","doi-asserted-by":"publisher","first-page":"5638","DOI":"10.1172\/jci137558","volume":"130","author":"SS Pullamsetti","year":"2020","unstructured":"Pullamsetti SS, Mamazhakypov A, Weissmann N, Seeger W, Savai R. Hypoxia-inducible factor signaling in pulmonary hypertension. J Clin Invest. 2020;130:5638\u201351. https:\/\/doi.org\/10.1172\/jci137558.","journal-title":"J Clin Invest"},{"key":"1478_CR92","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41569-022-00703-y","volume":"19","author":"JM Quiles","year":"2022","unstructured":"Quiles JM, Gustafsson \u00c5B. The role of mitochondrial fission in cardiovascular health and disease. Nat Rev Cardiol. 2022;19:723\u201336. https:\/\/doi.org\/10.1038\/s41569-022-00703-y.","journal-title":"Nat Rev Cardiol"},{"key":"1478_CR93","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.molcel.2023.11.016","volume":"84","author":"C Renz","year":"2024","unstructured":"Renz C, Asimaki E, Meister C, Alban\u00e8se V, Petriukov K, Krapoth NC, Wegmann S, Wollscheid HP, Wong RP, Fulzele A, et al. Ubiquiton-an inducible, linkage-specific polyubiquitylation tool. Mol Cell. 2024;84:386\u2013e400311. https:\/\/doi.org\/10.1016\/j.molcel.2023.11.016.","journal-title":"Mol Cell"},{"key":"1478_CR94","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1172\/jci83361","volume":"126","author":"AM Rothman","year":"2016","unstructured":"Rothman AM, Arnold ND, Pickworth JA, Iremonger J, Ciuclan L, Allen RM, Guth-Gundel S, Southwood M, Morrell NW, Thomas M, et al. MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension. J Clin Invest. 2016;126:2495\u2013508. https:\/\/doi.org\/10.1172\/jci83361.","journal-title":"J Clin Invest"},{"key":"1478_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.03.001","author":"AMK Rothman","year":"2025","unstructured":"Rothman AMK, Florentin A, Zink F, Quigley C, Bonneau O, Hemmig R, Hachey A, Rejtar T, Thaker M, Jain R, et al. Therapeutic potential of allosteric HECT E3 ligase inhibition. Cell. 2025. https:\/\/doi.org\/10.1016\/j.cell.2025.03.001.","journal-title":"Cell"},{"key":"1478_CR96","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jama.2022.4402","volume":"327","author":"NF Ruopp","year":"2022","unstructured":"Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension: a review. JAMA. 2022;327:1379\u201391. https:\/\/doi.org\/10.1001\/jama.2022.4402.","journal-title":"JAMA"},{"key":"1478_CR97","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ydbio.2008.05.524","volume":"320","author":"Y Sato","year":"2008","unstructured":"Sato Y, Heuckeroth RO. Retinoic acid regulates murine enteric nervous system precursor proliferation, enhances neuronal precursor differentiation, and reduces neurite growth in vitro. Dev Biol. 2008;320:185\u201398. https:\/\/doi.org\/10.1016\/j.ydbio.2008.05.524.","journal-title":"Dev Biol"},{"key":"1478_CR98","doi-asserted-by":"publisher","first-page":"8130","DOI":"10.1021\/acs.jmedchem.3c00229","volume":"66","author":"DE Shaw","year":"2023","unstructured":"Shaw DE, Smith N, Beerli R, Cotesta S, D\u2019Alessandro PL, Edwards AM, Lattmann R, Lizos D, Pulz R, Rooney L, et al. Design and synthesis of inhibitors of the E3 ligase SMAD specific E3 ubiquitin protein ligase 1 as a treatment for lung remodeling in pulmonary arterial hypertension. J Med Chem. 2023;66:8130\u20139. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00229.","journal-title":"J Med Chem"},{"key":"1478_CR100","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1161\/circulationaha.120.048191","volume":"142","author":"H Shen","year":"2020","unstructured":"Shen H, Zhang J, Wang C, Jain PP, Xiong M, Shi X, Lei Y, Chen S, Yin Q, Thistlethwaite PA, et al. MDM2-Mediated ubiquitination of angiotensin-converting enzyme 2 contributes to the development of pulmonary arterial hypertension. circulation. 2020;142:1190\u2013204. https:\/\/doi.org\/10.1161\/circulationaha.120.048191.","journal-title":"Circulation"},{"key":"1478_CR99","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.123.066430","author":"H Shen","year":"2024","unstructured":"Shen H, Gao Y, Ge D, Tan M, Yin Q, Wei TW, He F, Lee TY, Li Z, Chen Y, et al. BRCC3 Regulation of ALK2 in vascular smooth muscle cells: implication in pulmonary hypertension. Circulation. 2024. https:\/\/doi.org\/10.1161\/circulationaha.123.066430.","journal-title":"Circulation"},{"key":"1478_CR101","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/77060","volume":"25","author":"H Shimura","year":"2000","unstructured":"Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet. 2000;25:302\u20135. https:\/\/doi.org\/10.1038\/77060.","journal-title":"Nat Genet"},{"key":"1478_CR102","doi-asserted-by":"publisher","unstructured":"Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53. https:\/\/doi.org\/10.1183\/13993003.01913-2018.","DOI":"10.1183\/13993003.01913-2018"},{"key":"1478_CR103","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41569-019-0242-x","volume":"17","author":"L Southgate","year":"2020","unstructured":"Southgate L, Machado RD, Gr\u00e4f S, Morrell NW. Molecular genetic framework underlying pulmonary arterial hypertension. Nat Rev Cardiol. 2020;17:85\u201395. https:\/\/doi.org\/10.1038\/s41569-019-0242-x.","journal-title":"Nat Rev Cardiol"},{"key":"1478_CR104","doi-asserted-by":"publisher","unstructured":"Sun A, Chen Y, Tian X, Lin Q. The Role of HECT E3 ubiquitin ligases in colorectal cancer. Biomedicines. 2023;11. https:\/\/doi.org\/10.3390\/biomedicines11020478.","DOI":"10.3390\/biomedicines11020478"},{"key":"1478_CR105","doi-asserted-by":"publisher","unstructured":"Sun N, Wang YB, Huang J, Deng RW, He HY, Gao L, Gao X, Fan YL, Cong Y, Guo YL, et al. Irisin Attenuates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension via Ubiquitin-Mediated Regulation of ENO1. Adv Sci (Weinh). 2025;e00096. https:\/\/doi.org\/10.1002\/advs.202500096.","DOI":"10.1002\/advs.202500096"},{"key":"1478_CR106","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cellsig.2018.09.013","volume":"53","author":"Y Tan","year":"2019","unstructured":"Tan Y, Chen Y, Du M, Peng Z, Xie P. USF2 inhibits the transcriptional activity of Smurf1 and Smurf2 to promote breast cancer tumorigenesis. Cell Signal. 2019;53:49\u201358. https:\/\/doi.org\/10.1016\/j.cellsig.2018.09.013.","journal-title":"Cell Signal"},{"key":"1478_CR107","doi-asserted-by":"publisher","unstructured":"Tang H, Gupta A, Morrisroe SA, Bao C, Schwantes-An TH, Gupta G, Liang S, Sun Y, Chu A, Luo A et al. 2024. Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension. Circulation. https:\/\/doi.org\/10.1161\/circulationaha.123.065304","DOI":"10.1161\/circulationaha.123.065304"},{"key":"1478_CR108","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","volume":"25","author":"JM Tsai","year":"2024","unstructured":"Tsai JM, Nowak RP, Ebert BL, Fischer ES. Targeted protein degradation: from mechanisms to clinic. Nat Rev Mol Cell Biol. 2024;25:740\u201357. https:\/\/doi.org\/10.1038\/s41580-024-00729-9.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1478_CR109","doi-asserted-by":"publisher","first-page":"e67942","DOI":"10.1371\/journal.pone.0067942","volume":"8","author":"J Wang","year":"2013","unstructured":"Wang J, Xu L, Yun X, Yang K, Liao D, Tian L, Jiang H, Lu W. Proteomic analysis reveals that proteasome subunit beta 6 is involved in hypoxia-induced pulmonary vascular remodeling in rats. PLoS ONE. 2013a;8:e67942. https:\/\/doi.org\/10.1371\/journal.pone.0067942.","journal-title":"PLoS ONE"},{"key":"1478_CR114","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.vph.2012.07.006","volume":"58","author":"Q Wang","year":"2013","unstructured":"Wang Q, Zuo XR, Wang YY, Xie WP, Wang H, Zhang M. Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-\u03b1 antagonists via the suppression of TNF-\u03b1 expression and NF-\u03baB pathway in rats. Vascul Pharmacol. 2013b;58:71\u20137. https:\/\/doi.org\/10.1016\/j.vph.2012.07.006.","journal-title":"Vascul Pharmacol"},{"key":"1478_CR117","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/cvr\/cvw047","volume":"110","author":"X Wang","year":"2016","unstructured":"Wang X, Ibrahim YF, Das D, Zungu-Edmondson M, Shults NV, Suzuki YJ. Carfilzomib reverses pulmonary arterial hypertension. Cardiovasc Res. 2016;110:188\u201399. https:\/\/doi.org\/10.1093\/cvr\/cvw047.","journal-title":"Cardiovasc Res"},{"key":"1478_CR119","doi-asserted-by":"publisher","first-page":"L216","DOI":"10.1152\/ajplung.00538.2017","volume":"316","author":"Z Wang","year":"2019","unstructured":"Wang Z, Yang K, Zheng Q, Zhang C, Tang H, Babicheva A, Jiang Q, Li M, Chen Y, Carr SG, et al. Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2019;316:L216\u201328. https:\/\/doi.org\/10.1152\/ajplung.00538.2017.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1478_CR113","doi-asserted-by":"publisher","first-page":"117159","DOI":"10.1016\/j.lfs.2019.117159","volume":"242","author":"Q Wang","year":"2020","unstructured":"Wang Q, Shi W, Zhang Q, Feng W, Wang J, Zhai C, Yan X, Li M. Inhibition of Siah2 ubiquitin ligase ameliorates monocrotaline-induced pulmonary arterial remodeling through inactivation of YAP. Life Sci. 2020;242:117159. https:\/\/doi.org\/10.1016\/j.lfs.2019.117159.","journal-title":"Life Sci"},{"key":"1478_CR110","doi-asserted-by":"publisher","first-page":"100599","DOI":"10.1016\/j.jbc.2021.100599","volume":"296","author":"J Wang","year":"2021","unstructured":"Wang J, Yan X, Feng W, Wang Q, Shi W, Chai L, Zhang Q, Chen Y, Liu J, Qu Z, et al. S1P induces proliferation of pulmonary artery smooth muscle cells by promoting YAP-induced Notch3 expression and activation. J Biol Chem. 2021a;296:100599. https:\/\/doi.org\/10.1016\/j.jbc.2021.100599.","journal-title":"J Biol Chem"},{"key":"1478_CR116","doi-asserted-by":"publisher","first-page":"672159","DOI":"10.3389\/fcell.2021.672159","volume":"9","author":"W Wang","year":"2021","unstructured":"Wang W, Jiang Z, Zhang D, Fu L, Wan R, Hong K. Comparative transcriptional analysis of pulmonary arterial hypertension associated with three different diseases. Front Cell Dev Biol. 2021b;9:672159. https:\/\/doi.org\/10.3389\/fcell.2021.672159.","journal-title":"Front Cell Dev Biol"},{"key":"1478_CR111","doi-asserted-by":"publisher","first-page":"108199","DOI":"10.1016\/j.isci.2023.108199","volume":"26","author":"L Wang","year":"2023","unstructured":"Wang L, Huang J, Zhang R, Zhang M, Guo Y, Liu Y, Li C, Wang W, Ying S, Liu J, et al. Culin5 aggravates hypoxic pulmonary hypertension by activating TRAF6\/NF-\u03baB\/HIF-1\u03b1\/VEGF. iScience. 2023a;26:108199. https:\/\/doi.org\/10.1016\/j.isci.2023.108199.","journal-title":"iScience"},{"key":"1478_CR112","doi-asserted-by":"publisher","first-page":"108199","DOI":"10.1016\/j.isci.2023.108199","volume":"26","author":"L Wang","year":"2023","unstructured":"Wang L, Huang J, Zhang R, Zhang M, Guo Y, Liu Y, Li C, Wang W, Ying S, Liu J, et al. Cullin 5 aggravates hypoxic pulmonary hypertension by activating TRAF6\/NF-\u03baB\/HIF-1\u03b1\/VEGF. iScience. 2023b;26:108199. https:\/\/doi.org\/10.1016\/j.isci.2023.108199.","journal-title":"iScience"},{"key":"1478_CR115","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12931-024-02953-5","volume":"25","author":"R Wang","year":"2024","unstructured":"Wang R, Wang R, Zhou S, Liu T, Dang J, Chen Q, Chen J, Wang Z. Ubiquitination of angiotensin-converting enzyme 2 contributes to the development of pulmonary arterial hypertension mediated by neural precursor cell-expressed developmentally down-regulated gene 4-Like. Respir Res. 2024a;25:326. https:\/\/doi.org\/10.1186\/s12931-024-02953-5.","journal-title":"Respir Res"},{"key":"1478_CR118","doi-asserted-by":"publisher","first-page":"176828","DOI":"10.1016\/j.ejphar.2024.176828","volume":"980","author":"Y Wang","year":"2024","unstructured":"Wang Y, Han D, Chai L, Qiu Y, Liu J, Li D, Zhang Q, Shen N, Chen Y, Chen H, et al. MFN2-dependent mitochondrial dysfunction contributes to Relm-\u03b2-induced pulmonary arterial hypertension via USP18\/Twist1\/miR-214 pathway. Eur J Pharmacol. 2024b;980:176828. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176828.","journal-title":"Eur J Pharmacol"},{"key":"1478_CR121","doi-asserted-by":"publisher","first-page":"7189","DOI":"10.1021\/acs.jmedchem.1c00415","volume":"64","author":"Y Wu","year":"2021","unstructured":"Wu Y, Li Z, McDonough MA, Schofield CJ, Zhang X. Inhibition of the oxygen-sensing asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor: a potential hypoxia response modulating strategy. J Med Chem. 2021;64:7189\u2013209. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00415.","journal-title":"J Med Chem"},{"key":"1478_CR122","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s12276-022-00920-y","volume":"55","author":"Z Wu","year":"2023","unstructured":"Wu Z, Zhu L, Nie X, Wei L, Qi Y. USP15 promotes pulmonary vascular remodeling in pulmonary hypertension in a YAP1\/TAZ-dependent manner. Exp Mol Med. 2023;55:183\u201395. https:\/\/doi.org\/10.1038\/s12276-022-00920-y.","journal-title":"Exp Mol Med"},{"key":"1478_CR120","doi-asserted-by":"publisher","unstructured":"Wu K, Kwon SH, Zhou X, Fuller C, Wang X, Vadgama J, Wu Y. Overcoming challenges in small-molecule drug bioavailability: a review of key factors and approaches. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms252313121.","DOI":"10.3390\/ijms252313121"},{"key":"1478_CR123","doi-asserted-by":"publisher","unstructured":"Xian Y, Ye J, Tang Y, Zhang N, Peng C, Huang W, He G. 2024. Deubiquitinases as novel therapeutic targets for diseases. MedComm (2020) 5:e70036. https:\/\/doi.org\/10.1002\/mco2.70036","DOI":"10.1002\/mco2.70036"},{"key":"1478_CR125","doi-asserted-by":"publisher","first-page":"646687","DOI":"10.3389\/fcell.2021.646687","volume":"9","author":"D Xu","year":"2021","unstructured":"Xu D, Li C. Regulation of the SIAH2-HIF-1 axis by protein kinases and its implication in cancer therapy. Front Cell Dev Biol. 2021;9:646687. https:\/\/doi.org\/10.3389\/fcell.2021.646687.","journal-title":"Front Cell Dev Biol"},{"key":"1478_CR126","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3892\/ijo.2019.4711","volume":"54","author":"S Xu","year":"2019","unstructured":"Xu S, Hui L, Yang N, Wang Y, Zhao N, Jiang XJ. Upregulation of microRNA\u2013194\u20135p inhibits hypopharyngeal carcinoma cell proliferation, migration and invasion by targeting SMURF1 via the mTOR signaling pathway. Int J Oncol. 2019;54:1245\u201355. https:\/\/doi.org\/10.3892\/ijo.2019.4711.","journal-title":"Int J Oncol"},{"key":"1478_CR124","doi-asserted-by":"publisher","first-page":"110939","DOI":"10.1016\/j.cellsig.2023.110939","volume":"113","author":"C Xu","year":"2024","unstructured":"Xu C, Wang B, Li M, Dong Z, Chen N, Duan J, Zhou Y, Jin M, Chen R, Yuan W. FUNDC1\/USP15\/Drp1 ameliorated TNF-\u03b1-induced pulmonary artery endothelial cell proliferation by regulating mitochondrial dynamics. Cell Signal. 2024;113:110939. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110939.","journal-title":"Cell Signal"},{"key":"1478_CR127","doi-asserted-by":"publisher","unstructured":"Yang G, Shi R, Zhang Q. Hypoxia and oxygen-sensing signaling in gene regulation and cancer progression. Int J Mol Sci. 2020;21. https:\/\/doi.org\/10.3390\/ijms21218162.","DOI":"10.3390\/ijms21218162"},{"key":"1478_CR128","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13062-024-00489-8","volume":"19","author":"M Yang","year":"2024","unstructured":"Yang M, Wei Y, He X, Xia C. The deubiquitinating protein OTUD6B promotes lung adenocarcinoma progression by stabilizing RIPK1. Biol Direct. 2024;19:46. https:\/\/doi.org\/10.1186\/s13062-024-00489-8.","journal-title":"Biol Direct"},{"key":"1478_CR129","doi-asserted-by":"publisher","unstructured":"Ye P, Chi X, Cha JH, Luo S, Yang G, Yan X, Yang WH. Potential of E3 ubiquitin ligases in cancer immunity: opportunities and challenges. Cells. 2021;10. https:\/\/doi.org\/10.3390\/cells10123309.","DOI":"10.3390\/cells10123309"},{"key":"1478_CR130","doi-asserted-by":"publisher","unstructured":"Yin Z, Popelka H, Lei Y, Yang Y, Klionsky DJ. The roles of ubiquitin in mediating autophagy. Cells. 2020;9. https:\/\/doi.org\/10.3390\/cells9092025.","DOI":"10.3390\/cells9092025"},{"key":"1478_CR133","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1089\/ars.2017.7482","volume":"30","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Trautz B, Kra\u010dun D, Vogel F, Weitnauer M, Hochkogler K, Petry A, G\u00f6rlach A. Stabilization of p22phox by hypoxia promotes pulmonary hypertension. Antioxid Redox Signal. 2019;30:56\u201373. https:\/\/doi.org\/10.1089\/ars.2017.7482.","journal-title":"Antioxid Redox Signal"},{"key":"1478_CR132","doi-asserted-by":"publisher","unstructured":"Zhang W, Qi Y, Wu B. 2021. MicroRNA-146-5p Promotes pulmonary artery endothelial cell proliferation under hypoxic conditions through regulating USP3. Dis Markers 2021:3668422. https:\/\/doi.org\/10.1155\/2021\/3668422","DOI":"10.1155\/2021\/3668422"},{"key":"1478_CR131","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1161\/circresaha.124.325539","volume":"136","author":"J Zhang","year":"2025","unstructured":"Zhang J, Gu X, Cheng TL, Qi YJ, Liu DY, Wu N, Wang DP, Huang Y, Zhu ZM, Fan Y. ASH2L Deficiency in Smooth muscle drives pulmonary vascular remodeling. Circ Res. 2025;136:719\u201334. https:\/\/doi.org\/10.1161\/circresaha.124.325539.","journal-title":"Circ Res"},{"key":"1478_CR134","doi-asserted-by":"publisher","first-page":"6297","DOI":"10.1002\/jcp.30298","volume":"236","author":"JJ Zhou","year":"2021","unstructured":"Zhou JJ, Li H, Li L, Li Y, Wang PH, Meng XM, He JG. CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertension. J Cell Physiol. 2021;236:6297\u2013311. https:\/\/doi.org\/10.1002\/jcp.30298.","journal-title":"J Cell Physiol"},{"key":"1478_CR136","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4049\/jimmunol.1600447","volume":"197","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Wang L, Hao R, Zhao B, Sun L, Ye RD. Cutting edge: a cullin-5-TRAF6 interaction promotes TRAF6 polyubiquitination and lipopolysaccharide signaling. J Immunol. 2016;197:21\u20136. https:\/\/doi.org\/10.4049\/jimmunol.1600447.","journal-title":"J Immunol"},{"key":"1478_CR135","doi-asserted-by":"publisher","first-page":"204589402110461","DOI":"10.1177\/20458940211046131","volume":"11","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Zhang Q, Yan X, Liu L, Zhai C, Wang Q, Chai L, Li M. Ubiquitin-specific protease 7 mediates platelet-derived growth factor-induced pulmonary arterial smooth muscle cells proliferation. Pulm Circ. 2021;11:20458940211046131. https:\/\/doi.org\/10.1177\/20458940211046131.","journal-title":"Pulm Circ"},{"key":"1478_CR137","doi-asserted-by":"publisher","first-page":"769167","DOI":"10.3389\/fimmu.2021.769167","volume":"12","author":"M Zou","year":"2021","unstructured":"Zou M, Zeng QS, Nie J, Yang JH, Luo ZY, Gan HT. The Role of E3 ubiquitin ligases and deubiquitinases in inflammatory bowel disease: friend or foe? Front Immunol. 2021;12:769167. https:\/\/doi.org\/10.3389\/fimmu.2021.769167.","journal-title":"Front Immunol"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-026-01478-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01478-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01478-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:52:10Z","timestamp":1779753130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-026-01478-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":137,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1478"],"URL":"https:\/\/doi.org\/10.1186\/s10020-026-01478-5","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}